10Y UST5.11%+3.02%30Y MTG7.03%+1.15%SOFR3.88%+0.26%VNQ$90.72-0.49%XLRE$41.44-0.49%FED FUNDS3.88%
Real Estate Trail
Institutional Press Wire
REBusiness Online · Boston

Berkeley Garbe Underway on 150,000 SF Life Sciences Project in Billerica, Massachusetts

Via REBusiness Online · September 25, 2026
Compiled by Real Estate Trail Editorial · September 25, 2026

Why this matters

Commercial real estate continues to digest a multi-year reset in cost of capital. Transaction velocity is below the 2019-2021 trend but improving, cap rates have stabilized across most stabilized property types, and the bid-ask gap has narrowed materially in the past two quarters. Sponsors with permanent capital and operating platforms have an advantage in the current execution environment. Boston life sciences absorption has moderated from its 2021-2022 pace, and the market is working through a meaningful Cambridge sublease overhang. Multifamily and trophy office remain durable. The next twelve months will continue to reward underwriting discipline and operational sophistication over balance-sheet aggression.

Editorial analysis · Real Estate Trail Editorial

On the RET wire

Computed from Real Estate Trail’s own tracked coverage

Excerpt from REBusiness Online:
BILLERICA, MASS. —Berkeley Garbe, a Boston-based developer that is a joint venture between Berkeley Investments and German real estate company GARBE, is underway on construction of a 150,000-square-foot life sciences…
Read the full article at REBusiness Online →

External link. Real Estate Trail does not republish source content.

Related coverage — Boston

Connect CRE · Boston · Office

Return to Lender: Week of Sept. 24, 2026

A 32-story downtown Boston office tower is scheduled for a foreclosure auction Oct. 20 by Wells Fargo, the Boston Business Journal reported. The tower at 100 Summer St. is owned by Boston private equity firm Rockpoint…

Sep 24